Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Orexigen
Orexigen
[[video]Orexigen CEO Talks Obesity
Yahoo/CNBC
Tue, 02/9/10 - 09:53 am
Pharma CEOs
obesity
Orexigen
Michael Narachi
Biotech Drugs to Watch In 2010
Minyanville
Thu, 01/7/10 - 11:15 am
Arena Pharmaceuticals
Vivus
Orexigen
Novo Nordisk
Amylin
Eli Lilly
Biogen Idec
Acorda Therapeutics
Dendreon
MannKind
2010 FDA Decisions to Watch
Motley Fool
Sun, 01/3/10 - 11:41 am
FDA
Pfizer
Nektar
MannKind
Afresa
Eli Lilly
Amylin
Dendreon
Vivus
Alkermes
Arena Pharmaceuticals
Orexigen
Merck Ends deal with Arena
Yahoo/Zacks.com
Mon, 12/28/09 - 10:10 am
Arena Pharmaceuticals
obesity
Merck
atherosclerosis
Orexigen
Insider Buying Bodes Well For Orexigen
Seeking Alpha
Fri, 11/27/09 - 10:49 am
Orexigen
Vivus, Analyst in Obesity Drug Side-Effect Spat
TheStreet.com
Wed, 10/28/09 - 08:15 am
obesity
side effects
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
Why Estimates of Future Revenues for Obesity Drugs Are Likely Off the Mark
BNET Pharma
Mon, 10/19/09 - 06:45 pm
obesity
Qnexa
Vivus
Arena Pharmaceuticals
Orexigen
Contrave
Why Orexigen's Empatic News Is Good
Seeking Alpha
Fri, 10/2/09 - 10:29 am
Orexigen
obesity
Empatic
Arena Pharmaceuticals
Vivus
Surviving Wednesday's Wild Ride in Healthcare and Biotech
Seeking Alpha
Thu, 10/1/09 - 10:41 am
biotech
Caraco
Senomyx
Sucampo
Orexigen
Vivus
Sequenom
Biocryst
Stem Cell Summit Can't Excite Investors
Yahoo/Indie Research
Wed, 09/30/09 - 03:53 pm
stem cells
Neuralstem
Aastrom
Orexigen
Cytori
Osiris
Orexigen, Vivus shares rise on obesity drug data
Yahoo/AP
Wed, 09/30/09 - 03:51 pm
Orexigen
Vivus
obesity
Empatic
Qnexa
Orexigen says trial of 2nd obesity drug meets goal
Reuters
Wed, 09/30/09 - 10:51 am
Orexigen
obesity
drug trials
Empatic
Arena's Lorcaserin Has Safety Edge
Yahoo/Zacks.com
Mon, 09/21/09 - 10:13 am
Arena Pharmaceuticals
lorcaserin
obesity
Vivus
Orexigen
A Rise For Biopharma In The Fall?
CNBC
Wed, 09/16/09 - 04:25 pm
biotech
Arena Pharmaceuticals
Orexigen
Vivus
Amgen
Celgene
Analyst thinks sales of Arena's lorcaserin will trail other obesity drugs, downgrades stock
Yahoo/AP
Wed, 09/16/09 - 09:11 am
downgrades
Arena Pharmaceuticals
obesity
lorcaserin
Vivus
Orexigen
Vivus: A One Trick Pony
Seeking Alpha
Fri, 09/11/09 - 08:20 am
Vivus
Arena Pharmaceuticals
Orexigen
obesity
Qnexa
Weighing Arena's Obesity Drug: Biotech Mailbag
TheStreet.com
Fri, 09/4/09 - 07:42 am
Arena Pharmaceuticals
obesity
Biovest International
Vivus
Orexigen
Qnexa
lorcaserin
Cramer Likes Orexigen: Should You?
Seeking Alpha
Tue, 08/18/09 - 08:05 am
Orexigen
Contrave
obesity
Orexigen Therapeutics is “all about the FDA” right now
CNBC
Thu, 08/13/09 - 10:41 pm
Orexigen
FDA
Contrave
obesity
Orexigen Therapeutics' 2nd-quarter loss narrows on lower expenses for obesity drug development
Yahoo/AP
Sat, 08/8/09 - 12:25 pm
obesity
Orexigen
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
next ›
last »